Ubiquitination, a post-translational modification that involves a covalent attachment of ubiquitin to a protein substrate, is essential for cellular homeostatic maintenance. At the end of a three-enzyme cascade, E3 ubiquitin ligases (E3s) recruit substrates and promote or directly catalyze ubiquitin transfer to targets. These enzymes largely determine the specificity of the ubiquitination reaction. Genetic alteration, abnormal expression, or dysfunction of E3s account for the occurrence and progression of human cancers. Indeed, excessive degradation of relevant tumor-suppressor molecules and impaired disposal of oncogenic proteins have been linked to tumorigenesis. This review focuses on the emerging roles of HECT-type E3s in tumorigenesis, and emphasizes how perturbations of these enzymes contribute to cancer pathogenesis.

Bernassola, F., Chillemi, G., Melino, G. (2019). HECT-Type E3 Ubiquitin Ligases in Cancer. TRENDS IN BIOCHEMICAL SCIENCES, 44(12), 1057-1075 [10.1016/j.tibs.2019.08.004].

HECT-Type E3 Ubiquitin Ligases in Cancer

Bernassola F.;Melino G.
2019-12-01

Abstract

Ubiquitination, a post-translational modification that involves a covalent attachment of ubiquitin to a protein substrate, is essential for cellular homeostatic maintenance. At the end of a three-enzyme cascade, E3 ubiquitin ligases (E3s) recruit substrates and promote or directly catalyze ubiquitin transfer to targets. These enzymes largely determine the specificity of the ubiquitination reaction. Genetic alteration, abnormal expression, or dysfunction of E3s account for the occurrence and progression of human cancers. Indeed, excessive degradation of relevant tumor-suppressor molecules and impaired disposal of oncogenic proteins have been linked to tumorigenesis. This review focuses on the emerging roles of HECT-type E3s in tumorigenesis, and emphasizes how perturbations of these enzymes contribute to cancer pathogenesis.
dic-2019
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore BIO/11 - BIOLOGIA MOLECOLARE
English
Con Impact Factor ISI
HECT-type E3 ubiquitin ligases; cancer; protein degradation; ubiquitin; ubiquitination
Bernassola, F., Chillemi, G., Melino, G. (2019). HECT-Type E3 Ubiquitin Ligases in Cancer. TRENDS IN BIOCHEMICAL SCIENCES, 44(12), 1057-1075 [10.1016/j.tibs.2019.08.004].
Bernassola, F; Chillemi, G; Melino, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/228232
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 52
social impact